Our data from healthy controls and patients with DLBCL clearly show that CD14+HLA-DRlo/neg monocytes are distinct from immature LIN-CD33+HLA-DR- MDSCs. This evidence concerns the gene CD14 and diffuse large B-cell lymphoma.